Provided by Tiger Fintech (Singapore) Pte. Ltd.

Denali Therapeutics Inc.

13.95
-0.0400-0.29%
Post-market: 13.950.00000.00%16:46 EDT
Volume:2.21M
Turnover:31.36M
Market Cap:2.03B
PE:-5.22
High:14.66
Open:14.49
Low:13.83
Close:13.99
Loading ...

Why You Shouldn't Bet Against Denali (DNLI) Stock

Zacks
·
20 Mar

Denali Therapeutics Coverage Assumed by Morgan Stanley at Overweight

Dow Jones
·
08 Mar

Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Disc Medicine (IRON) and PTC Therapeutics (PTCT)

TIPRANKS
·
07 Mar

BRIEF-Denali Therapeutics Inc To Discontinue Active Treatment Extension In Regimen G

Reuters
·
06 Mar

Denali Therapeutics discontinues active treatment extension in eIF2B Regimen G

TIPRANKS
·
06 Mar

Denali Therapeutics Inc - to Discontinue Active Treatment Extension in Regimen G

THOMSON REUTERS
·
06 Mar

B. Riley Trims Price Target on Denali Therapeutics to $35 From $38, Keeps Buy Rating

MT Newswires Live
·
05 Mar

Stock Track | Denali Therapeutics Inc. (DNLI) Soars 5.33% in Pre-Market Trading on Positive Analyst Insights

Stock Track
·
05 Mar

Analysts Offer Insights on Healthcare Companies: Denali Therapeutics (DNLI), Ardent Health Partners, Inc. (ARDT) and Doximity (DOCS)

TIPRANKS
·
05 Mar

Stock Track | Denali Therapeutics Plummets 5.16% as Price Target Cut on Lowered Probability of Success

Stock Track
·
04 Mar

Denali Therapeutics price target lowered to $42 from $50 at Oppenheimer

TipRanks
·
04 Mar

Is Denali Therapeutics Inc. (DNLI) Among Jeff Bezos’ Investments in 2025?

Insider Monkey
·
04 Mar

Denali Therapeutics : Oppenheimer Cuts Target Price to $42 From $50

THOMSON REUTERS
·
03 Mar

Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus

Zacks
·
01 Mar

Denali Therapeutics (DNLI) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
28 Feb

Denali: Entered Equity Distribution Agreement, Pursuant to Which Co May Offer, Sell Shares of Co Common Stock of up to $400 Mln From Time to Time

THOMSON REUTERS
·
28 Feb

BRIEF-Denali Therapeutics Files For Mixed Shelf Size Not Disclosed - SEC Filing

Reuters
·
28 Feb

Denali Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Feb

Denali Therapeutics Inc Files for Mixed Shelf; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
28 Feb

BRIEF-Denali Therapeutics Q4 Operating Income USD -129.846 Million

Reuters
·
28 Feb